Page 30 - Umer Raffat News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Umer Raffat. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Umer Raffat Today - Breaking & Trending Today

Alkermes (ALKS) Q2 2022 Earnings Call Transcript

Published: July 27, 2022

ALKS earnings call for the period ending June 30, 2022.

Source: fool.com

Related Topics:

United StatesCory KasimovDouglas TsaoAkash TewariSandra CoombsJason GerberryBrandon Folkes Cantor FitzgeraldChris ShibutaniTodd NicholsIain BrownChris Shibutani Goldman SachsMarc GoodmanPaul MatteisBrandon FolkesCantor FitzgeraldPaul Matteis Stifel Financial CorpGoldman SachsPatient Copay Assistance ProgramCompany AnalystVice PresidentRichard PopsPatient Copay AssistanceUmer RaffatChief Executive

Biogen (BIIB) Q2 2022 Earnings Call Transcript

Published: July 20, 2022

BIIB earnings call for the period ending June 30, 2022.

Source: fool.com

Related Topics:

United StatesMichael HenckeMike McdonnellRobyn KarnauskasCory KasimovEvan SeigermanSalveen Richter Goldman SachsMike YeePriya SinghalMarc GoodmanJay Olson OppenheimerMichael YeePhil Nadeau CowenBrian AbrahamsSalveen RichterGeoff MeachamJay OlsonAmerica Merrill LynchMatthew Harrison Morgan StanleyMike Yee JefferiesMichel VounatsosAsia PacSamsung BioepisRobyn Karnauskas TruistMatthew Harrison

In 'unusual' move, FDA to reconvene advisers for ALS drug review

Published: July 5, 2022

BioPharma

Source: biopharmadive.com

Related Topics:

Tammy SarnelliMichael DifioreAmylyx PharmaceuticalsDrug AdministrationHealth CanadaDive BriefUmer Raffat

Amylyx's ALS drug gets approved in Canada

Published: June 13, 2022

BioPharma

Source: biopharmadive.com

Related Topics:

United StatesMichael DifioreJosh CohenMarc GoodmanAmylyx PharmaceuticalsDrug AdministrationHealth CanadaDive BriefBiopharma DiveWall StreetUmer Raffat

Roche keeps the faith in new cancer immunotherapy despite trial setbacks

Published: June 7, 2022

BioPharma

Source: biopharmadive.com

Related Topics:

United StatesCharles RudinCharles FuchsBristol MyersAmerican Society Of Clinical OncologyDrug AdministrationBristol Myers SquibbMemorial Sloan Kettering Cancer CenterAmerican SocietyClinical OncologyWall StreetUmer RaffatClinical Trials